Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

AIkido Pharma Inc (AIKI)

AIkido Pharma Inc (AIKI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.56 +0.01 (+0.28%) 12/21/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.56 unch (unch) -
Quote Overview for Wed, Dec 21st, 2022
Day Low
3.50
Day High
3.67
Open 3.55
Previous Close 3.55 3.55
Volume 31,900 31,900
Avg Vol 41,875 41,875
Stochastic %K 44.65% 44.65%
Weighted Alpha -62.60 -62.60
5-Day Change -0.12 (-3.26%) -0.12 (-3.26%)
52-Week Range 3.31 - 11.48 3.31 - 11.48
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,527
  • Shares Outstanding, K 5,485
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,170 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.93
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.24
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.88
  • Most Recent Earnings $-1.17 on 11/10/22
  • Next Earnings Date 11/16/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -1.11
  • Number of Estimates 1
  • High Estimate -1.11
  • Low Estimate -1.11
  • Prior Year -0.34
  • Growth Rate Est. (year over year) -226.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.31 +7.55%
on 12/07/22
Period Open: 4.04
4.20 -15.17%
on 11/22/22
-0.48 (-11.88%)
since 11/21/22
3-Month
3.31 +7.55%
on 12/07/22
Period Open: 6.88
7.27 -51.01%
on 10/05/22
-3.32 (-48.26%)
since 09/21/22
52-Week
3.31 +7.55%
on 12/07/22
Period Open: 11.03
11.48 -68.98%
on 01/04/22
-7.47 (-67.72%)
since 12/21/21

Most Recent Stories

More News
AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

/PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today announced the successful initial public offering ("IPO") of ASP Isotopes...

AIKI : 3.56 (+0.28%)
AIkido Share Repurchase Continues

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company's share repurchase program (the "Share...

AIKI : 3.56 (+0.28%)
Dominari Financial, Inc. Executes Definitive Agreement to Buy Broker-Dealer

/PRNewswire/ -- Dominari Financial, Inc., the financial services subsidiary of AIkido Pharma Inc., (NASDAQ: AIKI) has entered into an exclusive agreement for...

AIKI : 3.56 (+0.28%)
AIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services Subsidiary

/PRNewswire/ -- Anthony Hayes, CEO of AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company"), announced the hiring of Carlos Aldavero as President of...

AIKI : 3.56 (+0.28%)
AIkido Inc. Announces the Formation of a New Financial Services Subsidiary

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") announced the formation of a wholly owned subsidiary with the purpose of making...

AIKI : 3.56 (+0.28%)
AIkido Pharma Inc. Appoints New Director, Soo Yu

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the appointment of Ms. Soo Yu, as a director of the Company....

AIKI : 3.56 (+0.28%)

Business Summary

AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. AIkido Pharma Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 3.82
2nd Resistance Point 3.75
1st Resistance Point 3.65
Last Price 3.56
1st Support Level 3.48
2nd Support Level 3.41
3rd Support Level 3.31

See More

52-Week High 11.48
Fibonacci 61.8% 8.36
Fibonacci 50% 7.39
Fibonacci 38.2% 6.43
Last Price 3.56
52-Week Low 3.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective